News Focus
News Focus
icon url

dV1

02/14/20 3:26 AM

#246258 RE: tucaman #246256

Nice scripts, thanks tucaman
icon url

dV1

02/14/20 3:34 AM

#246259 RE: tucaman #246256

Thanks tucaman
icon url

Sabre2870

02/14/20 5:48 AM

#246262 RE: tucaman #246256

Tucamen, Thank you. The numbers are looking good.
icon url

SocialBoom

02/14/20 5:58 AM

#246265 RE: tucaman #246256

Wow, those look great. Thank you for posting.
icon url

fsulevine

02/14/20 7:04 AM

#246267 RE: tucaman #246256

Awesome!! Thank you!
icon url

Restingzebra

02/14/20 8:41 AM

#246271 RE: tucaman #246256

Great numbers. And a huge thanks again for picking up this very important reporting.
icon url

Babr

02/14/20 8:50 AM

#246272 RE: tucaman #246256

I can not believe there is still 60,000 generic Lovaza Prescriptions every week, Also there are tons of patients on Fish oil DS,by far majority of the patients in this space.
icon url

dukesking

02/14/20 9:00 AM

#246274 RE: tucaman #246256

Tucaman, Thanks for providing the scripts update.
icon url

MNBioMike

02/14/20 9:36 AM

#246285 RE: tucaman #246256

Thanks Tuca. With a modest 1.5% weekly growth, we'll finish around $780M in revs and a $1.1B run rate at the end of 2020. There's considerable upside to those #s as well.

BP's mouth is watering.....
icon url

Jimcal22

02/14/20 9:56 AM

#246287 RE: tucaman #246256

Tuc, thank you for taking on the script update!
icon url

Hondo1021

02/14/20 11:19 AM

#246303 RE: tucaman #246256

Kickass numbers. Onward!
icon url

tucaman

02/21/20 3:14 AM

#247337 RE: tucaman #246256

Scripts for week ending 02/14/2020
Below the updated script numbers. I included scripts for Lovaza (incl. Generic, though not sure I captured all suppliers) - for reference. I'll leave it to RAF and Sam to comment on plausibility of the figures.

Vascepa
TRx: 83'006 (+2.43%)
NRx: 41'098 (+4.44%)

Generic Lovaza

TRx: 60'250 (+1.12%)
NRx: 30'000 (+0.84%)
icon url

tucaman

03/06/20 5:31 AM

#250291 RE: tucaman #246256

Scripts for week ending 02/28/2020
Below the updated script numbers. I included scripts for Lovaza (incl. Generic, though not sure I captured all suppliers) - for reference. I'll leave it to RAF and Sam to comment on plausibility of the figures.

Vascepa
TRx: 79'920 (-1.28%)
NRx: 49'281 (+2.04%)

Generic Lovaza
TRx: 57'417 (-0.86%)
NRx: 28'500 (-1.16%)